Ketamine Follow-Up Questions When a Dose Isn’t Working

If a ketamine dose does not seem to be helping, your follow-up visit is the right time to discuss the pattern openly, not to change anything on your own. Ask what your clinician means by “not working,” how long they would reasonably expect change to take, whether your treatment goals still fit your symptoms, and whether safety or other treatments need attention first. In 2026, ketamine is still prescribed off-label for depression and most mental-health uses; esketamine (Spravato) is FDA-approved for treatment-resistant depression in a supervised program.

A disappointing session or two does not, by itself, establish that treatment has failed. Your prescriber should interpret your response in the context of your diagnosis, symptom history, therapy and medication plan, side effects, safety, and the type of care you are receiving. This article is educational, not medical advice; make treatment decisions with your licensed clinician.

Start by defining what “isn’t working” means

Ask your clinician to define the outcome being evaluated. Relief can mean fewer depressive symptoms, less suicidal thinking, improved function, better sleep, or greater ability to engage in therapy; these are not interchangeable. The National Institute of Mental Health describes depression as affecting mood, thinking, and daily activities, so a useful follow-up looks beyond whether you felt a noticeable change immediately after a session.

• “Which symptoms and functional goals are we tracking?”
• “What would count as a meaningful response for me?”
• “What timeline are you using to judge whether this plan is helping?”
• “Could my diagnosis or current symptoms suggest a different approach is needed?”

If goals were never made explicit, use the visit to reset them. These questions to ask about ketamine treatment goals at a first consultation can also help you frame a follow-up conversation.

Questions about the treatment plan

Ask for the clinical reasoning behind the next step rather than assuming that more treatment is automatically better. Research on ketamine for depression is promising but varies by setting, diagnosis, treatment protocol, and study design. A 2022 systematic review in The Lancet Psychiatry reported that ketamine and esketamine were associated with short-term antidepressant benefits in treatment-resistant depression, while also emphasizing limits in the available evidence and the need to consider adverse effects.

• “What are the possible reasons I have had little or no benefit so far?”
• “What alternatives are we considering besides changing this treatment?”
• “How does ketamine fit with my psychotherapy, current medications, and overall depression plan?”
• “What signs would tell us to pause, stop, or seek a different level of care?”

If your care is split between a ketamine service and another mental-health clinician, ask how information will be shared. Continuity is a practical safety issue; see these questions to ask a ketamine provider about continuity of care.

Ask directly about safety and setting

Limited benefit is only one part of the decision. The right question is whether the expected benefit still outweighs the burdens and risks for you. Ask how the provider is screening for contraindications, monitoring side effects, and responding if you need urgent help between visits. The FDA’s 2023 safety communication specifically says ketamine is not FDA-approved to treat psychiatric disorders and raises concerns about compounded ketamine used at home without appropriate monitoring.

Questions to take with you:

• “Which side effects are expected, and which mean I should contact you urgently?”
• “Does my medical or psychiatric history change the safety picture?”
• “What support, monitoring, and emergency instructions apply in my care setting?”
• “If care is at home, who is responsible for follow-up and what happens if I feel worse?”

Review who may not be a good candidate for ketamine and the broader ketamine therapy safety guide before your appointment if either topic is unclear.

Leave with a clear next-step plan

Before the visit ends, ask your clinician to summarize the decision in plain language: what you are trying next, why it is reasonable, what you should monitor, and when you will reassess. If the explanation is vague, ask what evidence or observations would lead them to recommend a different path.

You can also ask, “What would you recommend if I were your family member with this response?” This does not require a guarantee; it invites a candid explanation of uncertainty and options. If you are comparing providers or considering a second opinion, use a structured approach to choosing a ketamine clinic and consider how to find a ketamine provider with appropriate credentials, screening, and continuity of care.